Sustained ACE2 Expression by Probiotic Improves Integrity of Intestinal Lymphatics and Retinopathy in Type 1 Diabetic Model
Journal of Clinical Medicine · 11 authors, 3 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The authors treated diabetic male mice with LP-ACE2 via oral gavage for 3 months.
Full summary
958 CHARS
The authors treated diabetic male mice with LP-ACE2 via oral gavage for 3 months. Results showed that LP-ACE2 improved lacteal morphology and gut barrier integrity, leading to reduced circulating LDL cholesterol, triglycerides, and free fatty acids, and increased HDL cholesterol. In the retina, LP-ACE2 treatment repaired blood-retinal barrier dysfunction, reduced inflammation (increased ZO-1, reduced VCAM-1 expression), decreased the number of acellular capillaries, and improved visual function as measured by scotopic electroretinogram waves and visual acuity. The study suggests that increasing systemic ACE2 via a probiotic platform may improve retinal lipid metabolism and function. Limitations include the exclusive use of male mice, the reliance on mRNA expression data for lipid transporters without direct measurement of lipid synthesis/turnover, and the lack of confirmation of increased systemic and retinal ACE2 levels in this specific study.